Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo
- PMID: 17630980
- DOI: 10.1111/j.1471-4159.2007.04587.x
Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo
Erratum in
- J Neurochem. 2007 Nov;103(3):1272. Bogush, Alexey [added]
Abstract
Studies in continuously cultured cells have established that familial Alzheimer's disease (FAD) mutant presenilin 1 (PS1) delays exit of the amyloid precursor protein (APP) from the trans-Golgi network (TGN). Here we report the first description of PS1-regulated APP trafficking in cerebral neurons in culture and in vivo. Using neurons from transgenic mice or a cell-free APP transport vesicle biogenesis system derived from the TGN of those neurons, we demonstrated that knocking-in an FAD-associated mutant PS1 transgene was associated with delayed kinetics of APP arrival at the cell surface. Apparently, this delay was at least partially attributable to impaired exit of APP from the TGN, which was documented in the cell-free APP transport vesicle biogenesis assay. To extend the study to APP and carboxyl terminal fragment (CTF) trafficking to cerebral neurons in vivo, we performed subcellular fractionation of brains from APP transgenic mice, some of which carried a second transgene encoding an FAD-associated mutant form of PS1. The presence of the FAD mutant PS1 was associated with a slight shift in the subcellular localization of both holoAPP and APP CTFs toward iodixanol density gradient fractions that were enriched in a marker for the TGN. In a parallel set of experiments, we used an APP : furin chimeric protein strategy to test the effect of artificially forcing TGN concentration of an APP : furin chimera that could be a substrate for beta- and gamma-cleavage. This chimeric substrate generated excess Abeta42 when compared with wildtype APP. These data indicate that the presence of an FAD-associated mutant human PS1 transgene is associated with redistribution of the APP and APP CTFs in brain neurons toward TGN-enriched fractions. The chimera experiment suggests that TGN-enrichment of a beta-/gamma-secretase substrate may play an integral role in the action of mutant PS1 to elevate brain levels of Abeta42.
Similar articles
-
Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.Biochemistry. 1998 Nov 24;37(47):16465-71. doi: 10.1021/bi9816195. Biochemistry. 1998. PMID: 9843412
-
Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1.J Biol Chem. 2009 May 1;284(18):12145-52. doi: 10.1074/jbc.M808497200. Epub 2009 Mar 10. J Biol Chem. 2009. PMID: 19276086 Free PMC article.
-
Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells.J Biol Chem. 2000 Nov 24;275(47):36794-802. doi: 10.1074/jbc.M006986200. J Biol Chem. 2000. PMID: 10962005
-
Metabolism of presenilin 1: influence of presenilin 1 on amyloid precursor protein processing.Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S15-8. doi: 10.1016/s0197-4580(98)00026-8. Neurobiol Aging. 1998. PMID: 9562461 Review.
-
Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653281 Review.
Cited by
-
Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.Mol Neurodegener. 2010 Oct 11;5:40. doi: 10.1186/1750-1326-5-40. Mol Neurodegener. 2010. PMID: 20937087 Free PMC article.
-
Activation of mTOR: a culprit of Alzheimer's disease?Neuropsychiatr Dis Treat. 2015 Apr 9;11:1015-30. doi: 10.2147/NDT.S75717. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 25914534 Free PMC article. Review.
-
Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.J Biol Chem. 2010 Sep 10;285(37):28472-80. doi: 10.1074/jbc.M110.133520. Epub 2010 Jul 9. J Biol Chem. 2010. PMID: 20622013 Free PMC article.
-
Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.Am J Pathol. 2013 Aug;183(2):369-81. doi: 10.1016/j.ajpath.2013.05.005. Epub 2013 Jun 7. Am J Pathol. 2013. PMID: 23747948 Free PMC article.
-
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.Ann Neurol. 2010 Aug;68(2):220-30. doi: 10.1002/ana.22052. Ann Neurol. 2010. PMID: 20641005 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous